ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
k141_5018_43 # 42913 # 44391 # -1 # ID=11_43;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.387	k141_5018_43	42913	44391	-	Strict	950	972.23	msrC	97.15	3002819	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGAAAATTTAGCAATAAATATAACAAACCTGCAAGTTCGTTTTGGTAACCAGTTAGAATTATCTATTGATTCTCTTCGTGTCTATCAGCAAGATCGAATAGGAATCATAGGAGAAAATGGAGTCGGTAAATCAACGTTGCTGAAACTGATAGCCGGAGAACTTATCCCAAATCAAGGGAAAATCCAAACAGAGATCACTTTCAACTATCTGCCTCAATTAACCTATCTTGCTGAAACAAAGGATCTGAATTTGGAATTAGCCAGTCATTTCCAGTTAAAACTGGAAGAAACTTCGGAACGGAAATGGAGTGGAGGGGAAGAACGAAAGATCGAGTTGATACGTCTTCTTTCTTCTTATGAACAAGGGATGCTTCTAGACGAGCCGACGACCCATCTAGATAGAAAAAGTGTGGATCGACTGATTGAAGAGCTTCGTTATTATTATGGCACGCTGATTTTTGTTAGTCATGACCGCTATTTTCTAGATGAGCTGGCAACGAAAATCTGGGAAGTAAAAGACGGAGAAATCCGAGAGTTTTCGGGGAATTATAGTGCCTATCTCACTCAAAAGGAATTGGAGAAAAAGACTCAGCTACGAGAAGCAGAGTCGATCATGAAAGAGAAAAAACGATTGGAAAAATCGATCCAAGAAAAGAAAAAACAAGCGGAAAAGTTGGAAAAAGTGTCTAGTAAAAAGAAAAAGCAACAAATCAGACCGGATCGGTTGTCTTCCTCTAAACAAAAAGACAGTGTACAAAAAGCCATCCAAAAGAATGCGAAAACATTAGAGAGAAGACTCCAAAAAATAGGAGAAACAACTAAGCCGCAACAGATGAAACAAATCCGTTTTCCAGTACCAAAATCTCTTGCACTCCACAATCGTTATCCAATCATGGGACAAAATATCCAATTGGAAAGAAACGGGAGAATATTACTGATAAATAGCGATTTTCAATTTTCTTTAGGTAAAAAAATCGCGATTGTCGGCGAAAATGGTTCAGGTAAGACAACCTTATTGGAACATATCCGCAAACAAGGAGAAGGAATCCTCCTTTCGCCGAAAGTAAGCTTTCAAGTCTATCAGCAAAAGGATTATCAAATGACATCTGAAGAATCCGTCATTCGTTTTGTCATGAGACAAACAGAGTTTTCGGAATCGCTTGTCCGTAGTTTGCTGAATCACTTAGGGTTTGCTCAGGAAACTCTGACGAAACCGTTGTGTACGTTAAGTGGGGGAGAAGCGACCCGTTTGACGATTGCTTTGCTTTTTACTAAGCCAAGTAATGTGTTGCTGTTAGATGAACCGACTAATTTCATTGATATGGCAACGATCGAAGCTTTAGAGCAGCTGATGCAAGTATATCCGGGAACGATTTTGTTTACTTCTCATGATTCCTACTTTGTCGAACGTACGGCTGATGAAGTTTATGAAATAAAAGGGCAGAAAATAAAAAAAGTACTTACGAGAAATTTTTAA	MENLAINITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKSTLLKLIAGELIPNQGKIQTEITFNYLPQLTYLAETKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSVDRLIEELRYYYGTLIFVSHDRYFLDELATKIWEVKDGEIREFSGNYSAYLTQKELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNAKTLERRLQKIGETTKPQQMKQIRFPVPKSLALHNRYPIMGQNIQLERNGRILLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDMATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	MENLAVNITNLQVRFGNQLELSIDSLRVYQQDRIGIIGENGVGKTTLLKLIVGELIPNQGKIQTEITFNYLPQLTYLAEAKDLNLELASHFQLKLEETSERKWSGGEERKIELIRLLSSYEQGMLLDEPTTHLDRKSMDRLIEELRYYYGTLIFVSHDRYFLDELATKVWEVKDGEIREFPENYSAYLTQRELEKKTQLREAESIMKEKKRLEKSIQEKKKQAEKLEKVSSKKKKQQIRPDRLSSSKQKDSVQKAIQKNTKTLERRLQKIGETTKPQQMKQIRFPVPKSLELHNRYPIMGQNIQLERSGRTLLINSDFQFSLGKKIAIVGENGSGKTTLLEHIRKQGEGILLSPKVSFQVYQQKDYQMTSEESVIRFVMRQTEFSESLVRSLLNHLGFAQETLTKPLCTLSGGEATRLTIALLFTKPSNVLLLDEPTNFIDVATIEALEQLMQVYPGTILFTSHDSYFVERTADEVYEIKGQKIKKVLTRNF	100.00	gnl|BL_ORD_ID|1937|hsp_num:0	2054		
k141_33964_36 # 33643 # 34191 # -1 # ID=15_36;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.404	k141_33964_36	33643	34191	-	Strict	275	373.244	AAC(6')-Ii	99.45	3002556	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGATAATCAGTGAATTTGACCGTAATAATCCAGTATTGAAAGATCAGCTTTCTGATTTACTGAGACTGACTTGGCCGGAAGAATATGGAGACAGCTCGGCAGAAGAAGTAGAAGAAATGATGAATCCAGAACGGATCGCGGTAGCAGCGGTTGACCAAGATGAGTTAGTAGGATTTATTGGTGCAATCCCTCAATACGGTATCACAGGTTGGGAATTGCATCCATTAGTTGTAGAAAGCTCCCGACGAAAGAACCAAATAGGTACTCGATTAGTCAATTACTTAGAAAAAGAAGTAGCTTCCAGAGGAGGAATCACGATTTATTTAGGTACGGATGATTTAGACCATGGAACAACGTTAAGTCAAACGGACCTGTATGAGCATACATTTGATAAAGTGGCTTCCATCCAGAACCTTCGTGAACATCCCTATGAGTTCTATGAAAAATTAGGTTATAAAATCGTAGGTGTCTTACCAAATGCAAATGGCTGGGACAAACCGGATATTTGGATGGCAAAAACGATTATTCCTCGACCAGATTCTCAATAA	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYEHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	MIISEFDRNNPVLKDQLSDLLRLTWPEEYGDSSAEEVEEMMNPERIAVAAVDQDELVGFIGAIPQYGITGWELHPLVVESSRRKNQIGTRLVNYLEKEVASRGGITIYLGTDDLDHGTTLSQTDLYVHTFDKVASIQNLREHPYEFYEKLGYKIVGVLPNANGWDKPDIWMAKTIIPRPDSQ	100.00	gnl|BL_ORD_ID|1070|hsp_num:0	1050		
k141_34482_47 # 41260 # 42990 # -1 # ID=29_47;partial=00;start_type=GTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.399	k141_34482_47	41260	42990	-	Strict	960	989.564	efrA	82.64	3003948	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; rifamycin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	GTGAAACTAATGTGGCATTATACCATGCGTTATAAGAAATTCTTGTTTTTCAATTTTATATGCGTATTCGGTTTTATTTTGATTGAATTAGGACTTCCTACGATTTTAGCGCGTATGATTGATGTAGGAATCCGCAATGGTGATTTTGATTATGTGAAACAGCAAGGGATATTTATGATCGTTATTACCGTAATCGGTATTATTTTGAATATCTTGTTAGGTTATTTTGGTTCGAGGATCACGACCAATATCGTAGCAGATATTCGAGATGACTTGTTCGAAAAGATCCAAAGCTATTCGCATCAGGAGTACGAAAATTTAGGCGTATCTTCCTTGATCACTCGTACAACAAATGATGCTTATCAGATCATGTTGTTCCTGCAAAATATTTTACGTATCGGTTTCATGGCGCCGATGATGTTCGTTGTCAGTTTGTACATGGTCATGCGTACAAGTGTGACACTCAGCTTGTATGTAGTAGGCGCATTGCCTTTGCTATTATTGGCGGTCGTAGCGATTGCTAAGGTGTCTGAGCCGTTATCTAAAAAACAACAAAAAAACTTAGATAAAATCAATAGTATCTTGCGGGAAAACCTTTCAGGATTGCGTGTGATTCGCGCATTCGTCAATGAAAAGTTTGAAGAAAAACGCTTTGCTGTAGTCAATGAGAATTATGCTGCTAGTTCGAAAAGCTTGTTCCGTTTGATGGCTGTTGCACAACCAGGTTTTTATTTCTTATTTAATATCGTGATGGTATTGATCATTTGGAGCGGGGCAGTGCAAATCGATGCTGGCGAACTTCGGGTAGGAGATTTGATTGCATTTATCGAGTATATATTCCATGCCTTATTCTCATTCATGTTATTTGCCAGTGTGTTCATGATGTATCCAAGAGCAGCCGTTTCAGCTGGACGTATCCAAGAGGCACTAGATGCCAAACCTTCGATTGTAGAAGATCCAAATGGTATATCGGATACGAAGACTAAAGGGTATATCGAATTTCAAAATGTAACATTTGCTTATCCAGGCCATTCGCAAGAGCCAGTGATTCGAAATGTCAGTTTTACAGCCTCTCCAGGAGAAACCGTTGCTTTTATTGGAAGTACCGGTAGCGGAAAATCTACGTTGATTCAATTGATTCCTCGCTTTTATGATGTGAGTGAAGGAAAGATCTTGGTCGACGGAGTAGACGTGAGAGATTATCGGTTAAGCAAGTTGCGAGACAAGATTGGGTTTATTCCGCAAAAAGCGCTGCTATTTACTGGAACGATTGCCGATAATTTGCGATACGGGAAAGAAGATGCCACACAAGAAGAAATGGAACGTGCAGCTGAGATTGCTCAAGCTTCAGAATTCATTTCTCGAAAACCAGATGGATTTGACGAACATTTATCAGAAGGTGGTTCCAATTTTTCAGGCGGACAAAAACAACGATTGGCAATAGCCAGAGCCATCATACGCCGTCCGGAAATCTATATTTTTGATGACAGCTTTTCTGCATTAGATTATCAAACGGATGCGAAGTTACGTGCTCGTCTGAAAAAAGAAACAACAGAATCTACTGTATTGATCGTAGCACAACGTGTGGGAACGATCATGCATGCAGATAAGATCATCGTATTAAATGAAGGAGAAGTCGTCGGTATGGGGACACATCGGGAGTTGTTGGAAAAATGCCCGATTTATTATGATATTGCCGCTTCTCAATTATCAAAGGAGGAACTAGCATGA	MKLMWHYTMRYKKFLFFNFICVFGFILIELGLPTILARMIDVGIRNGDFDYVKQQGIFMIVITVIGIILNILLGYFGSRITTNIVADIRDDLFEKIQSYSHQEYENLGVSSLITRTTNDAYQIMLFLQNILRIGFMAPMMFVVSLYMVMRTSVTLSLYVVGALPLLLLAVVAIAKVSEPLSKKQQKNLDKINSILRENLSGLRVIRAFVNEKFEEKRFAVVNENYAASSKSLFRLMAVAQPGFYFLFNIVMVLIIWSGAVQIDAGELRVGDLIAFIEYIFHALFSFMLFASVFMMYPRAAVSAGRIQEALDAKPSIVEDPNGISDTKTKGYIEFQNVTFAYPGHSQEPVIRNVSFTASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGKILVDGVDVRDYRLSKLRDKIGFIPQKALLFTGTIADNLRYGKEDATQEEMERAAEIAQASEFISRKPDGFDEHLSEGGSNFSGGQKQRLAIARAIIRRPEIYIFDDSFSALDYQTDAKLRARLKKETTESTVLIVAQRVGTIMHADKIIVLNEGEVVGMGTHRELLEKCPIYYDIAASQLSKEELA	MKLMWRYTMRYKKLLFADFICVFGFILIELGLPTILARMIDKGIIPKDMDYVYQQGIWMVVITIIGVAMNILLGYFGARITTNIVRDIRDDLFEKIQTFSHSEYESIGVSSLITRTTNDAYQIMLFMGNILRLGFMTPVMFIASLYMVMRTSPSLGMYVLGALPFLLLAVVGIARLSEPLSKKQQKNLDGINGILRENLSGLRVIRAFVNEKFEESRFNKVNETYTKSSKSLFRLMAAAQPGFFFLFNIVMVLIIWSGTVQISHGDLEVGNLIAFIEYIFHALFSFMLFASVFMMYPRAAVSASRIQEALDMEPAIREEEGVTETATKGYLEFKNVTFAYPGHAESPVIRNVSFKASPGETVAFIGSTGSGKSTLIQLIPRFYDVSEGEILIDGVNVKEYKLSALRNKIGYIPQKALLFTGTIADNLRYGKEDATLEEMERAIDIAQATEFVSQKPQGYDEPLSEGGTNFSGGQKQRLAIARAIIRNPEIYIFDDSFSALDYQTDANLRARLKKETTESTVLIVAQRVGTIMHADRIVVLNEGDVVGIGTHRELLETCPIYYDIAASQLSEEELA	100.17	gnl|BL_ORD_ID|2240|hsp_num:0	2421		
k141_19227_47 # 46341 # 47936 # 1 # ID=45_47;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.392	k141_19227_47 	46341	47936	+	Strict	1000	993.801	eatAv	96.0	3003761	protein variant model	T450I	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGTATGGGTCTTTTTGTGTGCACCAAACCCTTGCATCCTCTTTAGCCAGTTCTGAAAATAGGACTGGTCTTTTTTTACGAGGTGATGGAATAATGTCTAAAATCGAAATAAAAAATCTGACATTCGGCTATGACAGCCAAGGCACATTATTATTTGAACAAGCCAATCTAAACTTTGACACCCAATGGAAACTAGGACTTATCGGACGAAACGGTCGAGGAAAGACAACTTTACTGAATATCCTGCAAAACAAACTCCCTTACCAAGGGCAAGTGATCCATCAGCAAGCGTTTGTCTATTTCCCGCAGCAAACAAAAGATAAAGAGCGTTTGACCTATTATGTGTTAAATGAGATTACGGATTTTGAGATATGGGAAATTGAAAGAGAGCTCCAACTGATGCAAACAGATCCTGAAATCTTATGGAGAGAATTCAGCACACTATCAGGAGGAGAGAAGACAAAAGTCCTACTGGCACTCTTATTTGTGGATGACACTCATTTCCCGTTAATCGATGAACCAACGAATCATTTGGATATCTCTGGCAGAAAACAAGTAGCGGCTTATTTGAAAAAGAAAAAACAAGGATTCATCGTGGTGAGTCATGATCGGGGATTTATCGATGAAGTAGTGGACCATGTTTTAGTAATCGAAAAGAGCCAACTGGAACTTTATCAAGGGAATTTCTCTATCTATGAAGAACAGAAAAAACTTCGTGATGAATTTGAAATAGCTAAAAATGAAAAATTGAAAAAAGAAGTCAGCAGGCTAAAGAAAACAGCGGCAGAAAAAGCAGAATGGTCTCGTTCCCGTGAAGGAGACAAAACAAAGAAAAAAGTCGGATTCATCGATACGGAATCTAGGCGAGTGAATAAAGGAGCAGTAGGCGCTGATGCTGCACGGACGATGAAACGATCTAAAGCAATCGTGAATCGGATGGAAACCCAGATCAGTGAGAAAGAAAAATTATTAAAAGATATCGAGTATATCGATGCTTTGACGATGAATAGTCAAGTGTCTCATCATAAACGGCTGTTAAGCGTAGAAAATCTTCAATTAGGGTATGAAAATCTGTTATTCGAGCCAGTTCACTTTACGATCGAACCTCATCAGCGGGTGGCAATTTCAGGTCCTAACGGCGCGGGAAAGTCATCCATTATCCATTATCTTCTGGGAACATTCAGCGGCAAGGTTGTAGGAGAAAAATCCCAGCCCAAACATTTGACCATTAGTTACGTACGCCAAAATTATGAAGACAATCGAGGGACGTTGGCGGAATTCGCGGAGAAAAACCGAGTAGACTACCAAGCATTTTTGAATAATCTCCGAAAGCTTGGGATGGAAAGAGATGTTTTTCATAACAAAATCGAACAGATGAGTATGGGGCAACGGAAAAAAGTGGAATTGGCTAAATCTTTATCACAACCAGCTGAGCTATATATATGGGATGAACCATTGAATTATTTGGATGTCTTCAATCAAGAACAATTAGAACAACTGATTTTGAACGTGAAACCTGCTATGTTACTAGTGGAACATGATCAAACCTTTCTAGATAAAGTATCTACTGAGATTATTTCTCTTGAGAAAATCTAA	MYGSFCVHQTLASSLASSENRTGLFLRGDGIMSKIEIKNLTFGYDSQGTLLFEQANLNFDTQWKLGLIGRNGRGKTTLLNILQNKLPYQGQVIHQQAFVYFPQQTKDKERLTYYVLNEITDFEIWEIERELQLMQTDPEILWREFSTLSGGEKTKVLLALLFVDDTHFPLIDEPTNHLDISGRKQVAAYLKKKKQGFIVVSHDRGFIDEVVDHVLVIEKSQLELYQGNFSIYEEQKKLRDEFEIAKNEKLKKEVSRLKKTAAEKAEWSRSREGDKTKKKVGFIDTESRRVNKGAVGADAARTMKRSKAIVNRMETQISEKEKLLKDIEYIDALTMNSQVSHHKRLLSVENLQLGYENLLFEPVHFTIEPHQRVAISGPNGAGKSSIIHYLLGTFSGKVVGEKSQPKHLTISYVRQNYEDNRGTLAEFAEKNRVDYQAFLNNLRKLGMERDVFHNKIEQMSMGQRKKVELAKSLSQPAELYIWDEPLNYLDVFNQEQLEQLILNVKPAMLLVEHDQTFLDKVSTEIISLEKI	MSKIEIKNLTFGYDSQGTLLFEQANLNFDTQWKLGLIGRNGRGKTTLLNILQNKLPYQGQVIHQQEFAYFPQQTKDKERLTYYVLNDITDFEIWEIERELQLMQTDPEILWREFSTLSGGEKTKVLLALLFVDDTHFPLIDEPTNHLDISGRKQVAAYLKKKKQGFIVVSHDRGFIDEVVDHVLAIEKSQLELYQGNFSIYEEQKKLRDEFEMAQNEKLKKEVSRLKKTAAEKAEWSRSREGDKTKKQVGFIDTESRRVNKGAVGADAARTMKRSKAIVNRMETQISEKEKLLKDIEYIDSLTMNSQASHHKRLLSVEDLQLGYENLLFEPIHFTIEPHQRVAISGPNGAGKSSIIHYLLGAFNGKVIGEKYQPKHLSISYASQNYEDNRGTLAEFAEKNQVDYQAFLNNLRKLGMERDVFHNKIEQMSMGQRKKVELAKSLSQPAELYIWDEPLNYLDVFNQEQLEQLILNVKPAMLLVEHDQTFLDKVSTEIISLERI	106.20	gnl|BL_ORD_ID|2119|hsp_num:0	2268	True	loose hit with at least 95 percent identity pushed strict
